AKT1 and glioblastoma: Previously, our findings indicated that combining TMZ with LIG could enhance the anti-GBM effect of TMZ, and LIG can enhance the anti-glioma effects of TMZ through the PI3K/Akt signaling pathway, indicating the potential of LIG to overcome resistance in GBM [25].